MedTrace Logo

Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting

NCT02937545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2021-06-03

Study results available
· View outcomes & findings →

Summary

This study aims to compare patient use of and satisfaction with community pharmacist-delivered pharmacogenetic (PGx) testing delivered along or as part of a medication therapy management (MTM) service. Pharmacist and patient outcome measures will be collected by surveys, interviews, and review of pharmacy records.

Conditions

  • Pharmacogenetics

Interventions

OTHER

Medication Therapy Management

Community pharmacists will provide medication therapy management in combination with pharmacogenetic testing

OTHER

Pharmacogenetic testing

Community pharmacist will provide pharmacogenetic testing.

Sponsors & Collaborators

  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH

  • Duke University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-22
Primary Completion
2019-09-10
Completion
2019-09-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02937545 on ClinicalTrials.gov